Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page has been updated to include the finalized citation for the phase 2b INCEPTION study on Tezepelumab, reflecting a new publication date and revision number. Additionally, a previous note about the modernization of ClinicalTrials.gov data ingest has been removed.
    Difference
    0.8%
    Check dated 2025-07-04T04:01:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-19T19:52:36.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:17:38.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.7%
    Check dated 2025-05-29T05:59:01.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:52:20.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page has been updated to include new publications related to the treatment of chronic spontaneous urticaria, specifically highlighting the results of the phase 2b INCEPTION study. Additionally, the revision number has been updated to v2.15.0, indicating a new version of the content.
    Difference
    16%
    Check dated 2025-04-16T01:49:47.000Z thumbnail image

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.